Tyvaso 0.6 MG refill kit
Ended Awarded
- Contract number
- 36C24526N0319
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $15,746
Award facts
- Contract value 100% obligated
- $15,746.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
United Therapeutics Corp was awarded a delivery order valued at $15,746.12 by Veterans Integrated Service Network (VISN) 5 on February 12, 2026, for Tyvaso 0.6 mg refill kits. This firm fixed-price delivery order, with an ultimate completion date of February 16, 2026, will be performed in Bartlett, Tennessee, and carries no set-aside designation. The award falls under the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB), through which United Therapeutics maintains a single-award Blanket Purchase Agreement with the Department of Veterans Affairs National Acquisition Center valued at $207.1 million with a ceiling date of April 23, 2026.
Tyvaso (treprostinil) is a critical therapeutic product used to treat pulmonary arterial hypertension in the veteran population. United Therapeutics Corp, a biotechnology manufacturer headquartered in Silver Spring, Maryland, serves as a primary supplier of specialized pharmaceutical products to the VA system. Through its BPA structure with the VA, the company provides four key medications—Unituxin, Remodulin, Tyvaso, and Orenitram—enabling VISNs across the country to efficiently procure these essential treatments at pre-negotiated prices while maintaining supply chain reliability and cost predictability for the Veterans Health Administration's mission to serve veterans nationwide.
Quick answers
Who was awarded contract 36C24526N0319?
36C24526N0319 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 12, 2026.
How much is contract 36C24526N0319 worth?
The government has obligated $15,746 on 36C24526N0319.
Is contract 36C24526N0319 an order under another contract?
Yes. 36C24526N0319 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0319 competed?
The extent of competition for 36C24526N0319 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award